Affluent Medical announces first patient implanted in OPTIMISE II pivotal clinical study for KALIOS, the minimally invasive mitral valve repair ring

  • KALIOS is the first fully adjustable mitral valve repair ring, designated for the percutaneous treatment of both residual and recurrent Mitral Regurgitation (MR).
  • First patient implanted in Vienna General Hospital (AKH)
  • Obtention of regulatory approval to start patient enrollment in 2 European countries already : Austria (Vienna) and Italy (Florence)
  • Affluent Medical plans on launching the device ni Europe by the end of 2021, subject to CE Marking